CLINICAL_TRIALS
trial_result
· 2013-03-26
Clinical Trial Update: Tiotropium Bromide in Cystic Fibrosis [Phase 3]
Summary
Phase 3 trial of tiotropium bromide in cystic fibrosis has completed. Boehringer Ingelheim posted the trial results in March 2013.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Boehringer Ingelheim | Conditions: Cystic Fibrosis | Phase 3 | Status: COMPLETED | Results posted: 2013-03-26